Lack of evidence for contribution of intron4a/b polymorphism of endothelial nitric oxide synthase (NOS3) gene to plasma nitric oxide levels

Acta Cardiologica

Volumn 63, Issue 2, 2008, Pages 229-234

  Salimi, Saeedeh ^a   Firoozrai, Mohsen ^b   Nourmohammadi, Issa ^b   Shabani, Mohammad ^b   Shafiee, S Mohammad ^b   Mohebbi, Ahmad ^c   Tavilani, Heidar ^d  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery disease; Nitric oxide; Nitric oxide synthase gene; Polymorphism

Indexed keywords

ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE PREDISPOSITION; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NOS3 GENE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ALLELES; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DNA; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS;

EID: 42249098269     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.2.2029533     Document Type: Article

References (31)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
2. Wang Y, Marsden PA. Nitric oxide synthase: biochemical and molecular regulation. Curr Opin Nephrol Hypertens 1995; 4: 12-22.
3. Waldman SA, Muard F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 1988; 12(Suppl 5): 15-8.
4. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui L-C, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-88.
5. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994; 198: 1027-33.
6. Yoon S, Moon J, Shin Ch, Kim E, Jo SA, Jo I. Smoking status-dependent association of the 27-bp repeat polymorphism in intron4 of endothelial nitric oxide synthase gene with plasma nitric oxide concentrations. Clinica Chimica Acta 2002; 324: 113-20.
7. Hingorani AD. Polymorphisms of endothelial nitric oxide synthase and atherogenesis. Atherosclerosis 2000; 154: 521-7.
8. Kone BC. Molecular biology of natriuretic peptides and nitric oxide synthase. Cardiovasc Res 2001; 51: 429-441.
9. Yashimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Saito Y, Miyamoto Y, Nakao K. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spam in the Japanese. Hum Genet 1998; 103: 65-9.
10. Yashimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Sumida H, Sugiyama S. Genetic risk factors for Coronary artery spam: significance of endothelial nitric oxide synthase gene T-786C and missence Glu298Asp variants. J Invest Med 2000; 48: 367-74.
11. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kujiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miamoto Y. T786C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-87.
12. Stangl K, Cascorbi I, Laule M. High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. Pharmacogenetics 2000; 10: 133-40.
13. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken D. Genetic contribution of endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc 1997; 17: 3147-53.
14. Tsukada T, Yokohama K, Aria T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J. Evidence of association of ecNOS gene polymorphism with plasma NO metabolic levels in humans. Biochem Biophys Res Commun 1998; 245: 190-3.
15. Yoon Y, Song J, Hong SH, Kim JQ. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000; 46: 1626-30.
16. Yoon S, Moon J, Shin C, Kim E, Jo SA, Jo I. Smoking status-dependent association of the 27-bp repeat polymorphism in intron 4 of endothelial nitric oxide synthase gene with plasma nitric oxide concentrations. Clin Chim Acta 2002; 324(1-2): 113-20.
17. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41-5.
18. 15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-8.
19. Umbach DM, Weinberg CR. Designing and analyzing case-control studies to exploit independence of genotype and exposure. Stat Med 1997; 16: 1731-43.
20. Loscalzo J, Welch G. Nitric oxide and its role in cardiovascular system. Prog Cardiovasc Dis 1995; 38: 87-104.
21. Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infraction in the Japanese population. Am J Cardiol 1998; 18: 83-6.
22. Matyar S, Attila G, Acarturk E, Akpinar O, Inal T. eNOS gene intron 4 a/b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey. Clin Chim Acta 2005; 354(1-2): 153-8.
23. Gardemann A, Lohre J, Cayci S, Katz N, Tillmanns H, Haberbosch W. The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerosis risk profile. Atherosclerosis 2002; 160: 167-75.
24. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y, Kihara M, Kimura K, Ishii M, Umemura S. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32: 521-6.
25. Wang J, Dudley D, Wang XL. Haplotype- specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arteroscler Thromb Vasc Biol 2002; 22: e1-e4.
26. Ordonez AJ, Carreira JM, Franco AG, Sanchez L, Alvarez MV, Garcia EC. Two expressive polymorphisms on the endothelial nitric oxide synthase gene (intron4, 27 bp repeat and -786 T/C) and the venous thrombosis. Thromb Res 2000; 99: 563-6.
27. Akar N, Akar E, Cin S, Deda G, Avcu F, Yalcin A. Endothelial nitric oxide synthase intron4, 27 bp repeat polymorphism in Turkish patients with deep vein thrombosis and cerebrovascular accidents. Thromb Res 1999; 94: 63-4.
28. Rao S, Austin H, Davidoff MN, Zafari AM. Endothelial nitric oxide synthase intron 4 polymorphism is a marker for coronary artery disease in African-American and Caucasian men. Ethn Dis 2005; 15(2): 191-7.
29. Sigusch HH, Suber R, Lehmann MH, Surber S, Weber J, Henke A, Reinhart D, Hoffmann A, Figulla HR. Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. Scand J Clin Lab Invest 2000; 60(3): 229-35.
30. Hwang JJ, Tasi CT, Yeh HM, Chiang FT, Hsu KL, Tseng CD, Liau CS, Tseng YZ, Lai LP. The 27-bp tandem repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene is not associated with coronary artery disease in a hospital-based Taiwanese population. Cardiology 2002; 97(2): 67-72.
31. Milutinovic A, Hruskovicova H. The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men. Folia Biol 2005; 51(2): 47-9.